{"id":969337,"date":"2026-06-02T07:52:35","date_gmt":"2026-06-02T11:52:35","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/"},"modified":"2026-06-02T07:52:35","modified_gmt":"2026-06-02T11:52:35","slug":"opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/","title":{"rendered":"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">RESEARCH TRIANGLE PARK, N.C., June  02, 2026  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=vwcpbrik_gRnvGXv10KcmaZtEEG4TdQ3-EmqJI42LZGBbWFpwHbWVuXiDsM4IjgwZHmlmzsXT2hxWwGEHUCvLdm3R0y3Ja_Ai9aYA2C0rkA=\" rel=\"nofollow\" target=\"_blank\">Opus Genetics, Inc.<\/a> (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced the guest speakers for its virtual Research &amp; Development (R&amp;D) Science Forum to be held on Tuesday, June 16, 2026, from 10:00 am \u2013 12:00 pm ET.<\/p>\n<p align=\"left\">The R&amp;D Science Forum will feature management and key opinion leaders (KOLs) highlighting Opus Genetics\u2019 multi-asset gene therapy pipeline, which is designed to address the underlying genetic causes of severe IRDs. The Forum will include detailed information on three gene therapy programs entering clinical testing, targeting the RDH12, MERTK, and RHO mutations. In addition, there will be a summary of recently presented data from the ongoing LCA5 and BEST1 clinical programs and an overview of IRD global market opportunities and patient prevalence.<\/p>\n<p align=\"left\">\u201cOur R&amp;D Science Forum brings together leading investigators and scientific experts to highlight the progress we are making within our gene therapy pipeline for inherited retinal diseases,\u201d said George Magrath, M.D., Chief Executive Officer, Opus Genetics. \u201cWith significant unmet needs across RDH12, MERTK, RHO, LCA5 and BEST1, we look forward to sharing our preclinical data, our deepening engagement with the clinical community, as well as our strategic development plans as we advance potentially transformative therapies for patients at risk of vision loss.\u201d<\/p>\n<p align=\"left\">\n        <strong>Opus Genetics\u2019 R&amp;D Science Forum Guest Speakers:<\/strong>\n      <\/p>\n<ul>\n<li>\n          <strong>Jean Bennett, MD, PhD<\/strong><br \/>\n          <br \/>Emeritus Professor of Ophthalmology, University of Pennsylvania \/ Scheie Eye Institute<\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>Todd Durham, PhD<\/strong><br \/>\n          <br \/>Senior Vice President, Clinical &amp; Outcomes Research, Foundation Fighting Blindness<\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>Kenneth C. Fan, MD, MBA<\/strong><br \/>\n          <br \/>Retina Specialist &amp; Surgeon, Retina Consultants of Texas<\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>Bart P. Leroy, MD, PhD<\/strong><br \/>\n          <br \/>Professor of Ophthalmology &amp; Head of Department, Ghent University Hospital<\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>Robert E. MacLaren, MB ChB, DPhil<\/strong><br \/>\n          <br \/>Professor of Ophthalmology, University of Oxford<\/li>\n<\/ul>\n<ul>\n<li>\n          <strong>Lejla Vajzovic, MD<\/strong><br \/>\n          <br \/>Professor of Ophthalmology, Duke University Eye Center<\/li>\n<\/ul>\n<p align=\"left\">\n        <strong>Webcast Registration:<\/strong>\n      <\/p>\n<p align=\"left\">Registration for the event is available on the\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fZqpp6GDjmCbjzOvVmnqy9GEmbBWcucRJK_Ca5gE_SN5TiVG1Q_Dh3fXBe6qHSYIZ8xfWQ6ycwqjypNu_BKIUQ==\" rel=\"nofollow\" target=\"_blank\">Events<\/a>\u00a0page of the Opus Genetics website. There will also be an archived replay available following the event.<\/p>\n<p align=\"left\">\n        <strong>About Opus Genetics<\/strong>\n      <\/p>\n<p align=\"left\">Opus Genetics is a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs). The Company is developing durable, one-time treatments designed to address the underlying genetic causes of severe retinal disorders. The Company\u2019s pipeline includes seven AAV-based programs, led by OPGx-LCA5 for LCA5-related mutations and OPGx-BEST1 for BEST1-related retinal degeneration, with additional candidates targeting RDH12, MERTK, RHO, CNGB1 and NMNAT1. The Company is based in Research Triangle Park, NC. For more information, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=7chM9t9toKHIxyjnsju0VfGEHwRtRmelN5Vp1yqevlxxIrMKKkpvQAUeZnsVcX-NsB9AoYDT9Eqws_Kt9f9Cag==\" rel=\"nofollow\" target=\"_blank\">www.opusgtx.com<\/a>.<\/p>\n<p align=\"left\">\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p align=\"left\">\n        <strong>Investors<\/strong><br \/>\n        <br \/>Jenny Kobin<br \/>Remy Bernarda<br \/>IR Advisory Solutions<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MQeD1MoVt783G_bPHmpGFeS31NM3MiTGfajY8K5zCsWMypzEyjLU700Q3I_rCj6Lx25hMd8I9vnSPveHkfT7Aw==\" rel=\"nofollow\" target=\"_blank\">ir@opusgtx.com<\/a><\/p>\n<p align=\"left\">\n        <strong>Media<\/strong><br \/>\n        <br \/>Kimberly Ha<br \/>KKH Advisors<br \/>917-291-5744<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=u6zoXyGWaXe_4r_mtGsNWoyhubC6BGhBXGqeyi0hYFvRikVd6kCiCVCbMCCn5-xW47C0yiI4OT683MNGhxpaIf1cNU4rdi0xpdgq-aXuPi7vgjLXXdRYaE08RIleMTme\" rel=\"nofollow\" target=\"_blank\">kimberly.ha@kkhadvisors.com<\/a><\/p>\n<p align=\"left\">Source: Opus Genetics, Inc.<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YmE1MDg1ZjMtMjMyNy00ZjcxLWE2NDktM2NiYmFmNjcyNWY5LTEzMTMzMTAtMjAyNi0wNi0wMi1lbg==\/tiny\/Opus-Genetics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RESEARCH TRIANGLE PARK, N.C., June 02, 2026 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced the guest speakers for its virtual Research &amp; Development (R&amp;D) Science Forum to be held on Tuesday, June 16, 2026, from 10:00 am \u2013 12:00 pm ET. The R&amp;D Science Forum will feature management and key opinion leaders (KOLs) highlighting Opus Genetics\u2019 multi-asset gene therapy pipeline, which is designed to address the underlying genetic causes of severe IRDs. The Forum will include detailed information on three gene therapy programs entering clinical testing, targeting the RDH12, MERTK, and RHO &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-969337","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RESEARCH TRIANGLE PARK, N.C., June 02, 2026 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced the guest speakers for its virtual Research &amp; Development (R&amp;D) Science Forum to be held on Tuesday, June 16, 2026, from 10:00 am \u2013 12:00 pm ET. The R&amp;D Science Forum will feature management and key opinion leaders (KOLs) highlighting Opus Genetics\u2019 multi-asset gene therapy pipeline, which is designed to address the underlying genetic causes of severe IRDs. The Forum will include detailed information on three gene therapy programs entering clinical testing, targeting the RDH12, MERTK, and RHO &hellip; Continue reading &quot;Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-02T11:52:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts\",\"datePublished\":\"2026-06-02T11:52:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/\"},\"wordCount\":483,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/\",\"name\":\"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=\",\"datePublished\":\"2026-06-02T11:52:35+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/","og_locale":"en_US","og_type":"article","og_title":"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts - Market Newsdesk","og_description":"RESEARCH TRIANGLE PARK, N.C., June 02, 2026 (GLOBE NEWSWIRE) &#8212; Opus Genetics, Inc. (Nasdaq: IRD) (\u201cOpus Genetics\u201d or the \u201cCompany\u201d), a clinical-stage biopharmaceutical company developing gene therapies to restore vision and prevent blindness in patients with inherited retinal diseases (IRDs), today announced the guest speakers for its virtual Research &amp; Development (R&amp;D) Science Forum to be held on Tuesday, June 16, 2026, from 10:00 am \u2013 12:00 pm ET. The R&amp;D Science Forum will feature management and key opinion leaders (KOLs) highlighting Opus Genetics\u2019 multi-asset gene therapy pipeline, which is designed to address the underlying genetic causes of severe IRDs. The Forum will include detailed information on three gene therapy programs entering clinical testing, targeting the RDH12, MERTK, and RHO &hellip; Continue reading \"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-02T11:52:35+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts","datePublished":"2026-06-02T11:52:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/"},"wordCount":483,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/","name":"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=","datePublished":"2026-06-02T11:52:35+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTc1NyM3NjI4MjU0IzIzMDE3NjA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/opus-genetics-to-host-virtual-rd-science-forum-on-tuesday-june-16-2026-featuring-multiple-inherited-retinal-disease-experts\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Opus Genetics to Host Virtual R&amp;D Science Forum on Tuesday, June 16, 2026 Featuring Multiple Inherited Retinal Disease Experts"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969337","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=969337"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/969337\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=969337"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=969337"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=969337"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}